• Users Online: 307
  • Home
  • Print this page
  • Email this page
Home Current issue Ahead of print Search About us Editorial board Archives Submit article Instructions Subscribe Contacts Login 
CASE REPORT
Year : 2019  |  Volume : 24  |  Issue : 1  |  Page : 60-62

Memantine as an augmentation therapy in obsessive–Compulsive disorder


Department of Psychiatry, Maharishi Markandeshwar Institute of Medical Sciences and Research, Ambala, Haryana, India

Correspondence Address:
Shazia Anjum
Block-H Flat No. 11 MMU, Mullana, Ambala - 133 207, Haryana
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/jmhhb.jmhhb_20_19

Rights and Permissions

Obsessive Compulsive Disorders a mental illness, which is long lasting and the person has recurrent thoughts or mental images and compulsive acts, which the person is unable to resist. SSRI and TCA are primarily used drugs for obsessive-compulsive disorder (OCD), but in few patients these lead to less response and some other augmenting drugs have to be added along with them. A role for glutamatergic dysfunction in the pathophysiology of OCD has been found. We report 2 cases with a diagnosis of OCD where the patients did not show good response on YBOCS with SSRI and other adjunctive drugs like venlafaxine, resperidone in adequate dose and duration. When memantine was added (20 mg) the patient showed improvement on YBOCS where score reduced within the 6 weeks of augmentation.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed74    
    Printed3    
    Emailed0    
    PDF Downloaded21    
    Comments [Add]    

Recommend this journal